Form 4 for TSHA Taysha Gene Therapies, Inc.
Accepted 2022-11-02 00:00:00 ET · period of report 2022-10-31 · accession 0001209191-22-055263 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-02 | 2022-10-31 | TSHA | Manning Paul B | Dir, 10% | P - Purchase | $2.00 | +1.50M | 1.64M | +1,055% | +$3.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-31 | P | A | 1,500,000 | $2.00 | 1,642,202 | D | — | — | (F1) Consists of 1,500,000 shares of common stock held by Mr. Manning and 142,202 shares of common stock held by Mr. Manning jointly with his spouse. |